ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,759Medicare Part D Prescriptions Filled, Including Refills

Rank: 238 out of 780

$508K Total Retail Price of All Prescriptions

Rank: 289 out of 780

489 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 7,372 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 932 365 S3 1 1
AMLODIPINE BESYLATE 448 316 2 4
SIMVASTATIN 347 275 3 2
OMEPRAZOLE 301 219 4 3
LISINOPRIL 283 189 5 6
LEVOTHYROXINE SODIUM 263 153 6 5
FUROSEMIDE 253 195 7 7
PRAVASTATIN SODIUM 221 144 8 9
METFORMIN HCL 221 145 8 8
ATORVASTATIN CALCIUM 219 122 10 12
MELOXICAM 212 136 11 16
HYDROCHLOROTHIAZIDE 209 149 12 10
TRAMADOL HCL 196 170 13 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 191 103 14 26
CARISOPRODOL 173 64 R 15 67
METFORMIN HCL ER 160 78 16 43
ZOLPIDEM TARTRATE 157 86 17 17
PANTOPRAZOLE SODIUM 156 105 18 25
CLONIDINE HCL 152 106 19 28
METOPROLOL TARTRATE 147 59 20 19
CARVEDILOL 144 86 21 14
KLOR-CON M20 142 85 22 57
FELODIPINE ER 132 107 23 126
ATENOLOL 112 96 24 21
GABAPENTIN 110 73 25 13
PROMETHAZINE HCL 108 34 R 26 66
LOVASTATIN 100 88 27 47
NEXIUM 98 52 28 22
SERTRALINE HCL 95 40 29 27
NAPROXEN 94 56 30 100
LOSARTAN-HYDROCHLOROTHIAZIDE 93 85 31 33
CLOPIDOGREL 91 45 32 34
CITALOPRAM HBR 90 39 33 23
ALENDRONATE SODIUM 89 79 34 44
POTASSIUM CHLORIDE 86 46 35 11
LANTUS SOLOSTAR 85 61 36 121
CRESTOR 79 61 37 32
TRAZODONE HCL 78 16 38 35
NIFEDIPINE ER 75 67 39 115
LOSARTAN POTASSIUM 75 59 39 18
ALLOPURINOL 72 33 41 29
LYRICA 67 46 42 52
IBUPROFEN 62 32 43 93
PLAVIX 61 38 44 45
AMITRIPTYLINE HCL 61 39 R 44 48
AMOXICILLIN 61 35 44 99
GLIMEPIRIDE 59 57 47 30
CYCLOBENZAPRINE HCL 59 17 R 47 42
DIOVAN 56 39 49 55
POLYETHYLENE GLYCOL 3350 56 40 49 79
HYDRALAZINE HCL 55 29 51 54
DONEPEZIL HCL 55 55 51 31
WARFARIN SODIUM 54 44 53 24
METOPROLOL SUCCINATE 53 40 54 20
AMLODIPINE BESYLATE-BENAZEPRIL 52 33 55 50
ADVAIR DISKUS 51 28 56 68
DIOVAN HCT 50 26 57 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.